Unicycive Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 1.41 M | $6.63 M | 3,836.67% | 5.25% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 1.40 M | $6.57 M | 49.22% | 5.21% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.07 M | $5.03 M | 32.05% | 3.98% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2026 | 1.00 M | $4.69 M | 0.00% | 3.72% |
| DIADEMA PARTNERS LP | 08/14/2026 | 792.60 K | $3.72 M | 100.00% | 2.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 564.02 K | $2.65 M | 176.83% | 2.10% |
| VIVO CAPITAL, LLC | 08/14/2026 | 550.00 K | $2.58 M | -69.27% | 2.04% |
| MARSHALL WACE, LLP | 08/13/2026 | 547.86 K | $2.57 M | 253.60% | 2.04% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 473.56 K | $2.22 M | 0.00% | 1.76% |
| STATE STREET CORP | 08/07/2026 | 450.16 K | $2.11 M | 462.51% | 1.67% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 420.00 K | $1.97 M | 100.00% | 1.56% |
| DIAMETRIC CAPITAL, LP | 08/14/2026 | 374.13 K | $1.75 M | 365.56% | 1.39% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 334.80 K | $1.57 M | 348.79% | 1.24% |
| J. GOLDMAN & CO LP | 08/14/2026 | 327.35 K | $1.54 M | 100.00% | 1.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 314.80 K | $1.48 M | -2.99% | 1.17% |
| DIADEMA PARTNERS LP | 08/14/2026 | 303.68 K | $1.42 M | 186.26% | 1.13% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 271.46 K | $1.27 M | -80.60% | 1.01% |
| DAUNTLESS INVESTMENT GROUP, LLC | 08/13/2026 | 214.00 K | $1.00 M | 45.49% | 0.80% |
| CITIGROUP INC | 08/03/2026 | 182.65 K | $856.65 K | 18,265,300.00% | 0.68% |
| NORTHERN TRUST CORP | 08/13/2026 | 181.93 K | $853.25 K | 406.25% | 0.68% |
| JANE STREET GROUP, LLC | 08/14/2026 | 178.90 K | $839.04 K | 318.97% | 0.66% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 169.20 K | $793.53 K | 100.00% | 0.63% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 160.04 K | $750.58 K | -19.67% | 0.59% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 153.00 K | $717.57 K | 100.00% | 0.57% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 148.97 K | $698.65 K | 47.38% | 0.55% |
| CITADEL ADVISORS LLC | 09/02/2026 | 147.70 K | $692.71 K | 79.03% | 0.55% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 145.30 K | $681.48 K | 436.32% | 0.54% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 143.05 K | $678.02 K | 0.00% | 0.53% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 110.00 K | $515.90 K | 100.00% | 0.41% |
| MORGAN STANLEY | 08/13/2026 | 109.65 K | $514.24 K | -41.73% | 0.41% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 103.40 K | $521.14 K | 85.64% | 0.38% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 08/13/2026 | 95.02 K | $445.64 K | 100.00% | 0.35% |
| CITADEL ADVISORS LLC | 09/02/2026 | 92.50 K | $433.83 K | 264.17% | 0.34% |
| PERSISTENT ASSET PARTNERS LTD | 08/07/2026 | 90.17 K | $422.87 K | 236.10% | 0.34% |
| SCIENTECH RESEARCH LLC | 08/14/2026 | 74.49 K | $349.36 K | 100.00% | 0.28% |
| UBS GROUP AG | 08/13/2026 | 69.38 K | $325.38 K | 256.80% | 0.26% |
| CITADEL ADVISORS LLC | 09/02/2026 | 61.17 K | $286.88 K | -74.17% | 0.23% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 54.84 K | $257.21 K | 100.00% | 0.20% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 54.84 K | $257.21 K | 100.00% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 52.81 K | $247.67 K | 100.00% | 0.20% |
| CANTOR FITZGERALD, L. P. | 08/19/2026 | 50.00 K | $234.50 K | -33.33% | 0.19% |
| NUVEEN, LLC | 08/11/2026 | 47.82 K | $224.28 K | 100.00% | 0.18% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 40.42 K | $189.58 K | 594.54% | 0.15% |
| BARCLAYS PLC | 08/14/2026 | 39.00 K | $182.92 K | -22.00% | 0.14% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 31.64 K | $148.38 K | 7.14% | 0.12% |
| JANE STREET GROUP, LLC | 08/14/2026 | 29.50 K | $138.36 K | -28.40% | 0.11% |
| RHUMBLINE ADVISERS | 08/12/2026 | 29.29 K | $137.35 K | 100.00% | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2026 | 27.72 K | $130.00 K | 126.63% | 0.10% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 24.27 K | $113.85 K | 100.00% | 0.09% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 22.07 K | $103.50 K | 100.00% | 0.08% |
Unicycive Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 92 institutional investors and hedge funds held shares of Unicycive Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 1.41 M
Nantahala Capital Management, LLC: 1.4 M
VANGUARD CAPITAL MANAGEMENT LLC: 1.07 M
Octagon Capital Advisors LP: 1,000,000
GEODE CAPITAL MANAGEMENT, LLC: 564,019
Vivo Capital, LLC: 550,000
43.34% of Unicycive Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 12.55 M shares in the last 24 months. This purchase volume represents approximately $88.48 M in transactions.